02096.HK
Simcere Pharmaceutical Group Limited
HKSE · Healthcare · Biotechnology · CN
HKD 11.17
−0.89%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 13.84x
- P/E 2027E
- 11.37x
- P/E 2028E
- 9.99x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 15.66x
- PEG TTM
- 1.00x
- Price / book
- 2.55x
- Price / sales
- 2.77x
- Price / cash flow
- 11.92x
Enterprise value
- Enterprise value
- HKD 24.8B
- EV / sales
- 2.45x
- EV / EBITDA
- 10.36x
- EV / EBIT
- 11.70x
- Market cap
- HKD 28.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026